Novo Nordisk A/S (NVO)

48.93 +0.19 (+0.39%) USD  |  NYSE  |  Feb 12, 16:00
49.66 +0.73 (+1.49%) Pre-Market: 07:14
More

Novo Nordisk EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Ascendis Pharma A/S --
Evaxion AS --
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --
DBV Technologies SA --